Deals Shaping The Medical Industry, September 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
You may also be interested in...
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
Newly launched with a $90m series A funding round, the company is taking the idea behind KRAS G12C inhibitors to another level.
A pair of medical experts discuss traumatic brain injuries, their treatments, and some of the long-term complications they can cause, especially when not properly diagnosed and treated.